Skip to content
10-Q

Quarterly Report

DICE THERAPEUTICS, INC.

0001564590-22-019841

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 6, 2022 38.23M sh
Long Term Debt Q1 2022 · Mar 31, 2022 $1.71M
Long Term Debt Q1 2022 · Dec 31, 2021 $1.92M
Short Term Debt Q1 2022 · Mar 31, 2022 $714K
Short Term Debt Q1 2022 · Dec 31, 2021 $480K
Current Liabilities Q1 2022 · Mar 31, 2022 $14.79M
Current Liabilities Q1 2022 · Dec 31, 2021 $10.88M
Total Liabilities Q1 2022 · Mar 31, 2022 $29.44M
Total Liabilities Q1 2022 · Dec 31, 2021 $12.81M
Current Assets Q1 2022 · Mar 31, 2022 $307M
Current Assets Q1 2022 · Dec 31, 2021 $323.91M
Total Assets Q1 2022 · Mar 31, 2022 $324.61M
Total Assets Q1 2022 · Dec 31, 2021 $325.75M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $115.83M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $24.72M
Capex Q1 2022 · Mar 31, 2021 $365K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$8M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$60.87M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$53.15M
Sga Expense Q1 2022 · Mar 31, 2021 $1.47M
Rd Expense Q1 2022 · Mar 31, 2021 $6.62M
Net Income Q1 2022 · Mar 31, 2021 −$8.07M
Operating Income Q1 2022 · Mar 31, 2021 −$8.09M